Imidazopyrazine Derivatives As Inhibitors of mTOR

被引：1
|
作者：
Rosse, Gerard [1 ,2 ]
机构：
[1] Dart Neurosci LLC, Struct Guided Chem, San Diego, CA 92121 USA
[2] Drexel Univ, Coll Med, Dept Physiol & Pharmacol, Philadelphia, PA 19102 USA
来源：
ACS MEDICINAL CHEMISTRY LETTERS | 2013年 / 4卷 / 06期
关键词：
D O I：
10.1021/ml400139e
中图分类号：
R914 [药物化学];
学科分类号：
100701 ;
摘要：
引用
收藏
页码：498 / 499
页数：2
相关论文
共 50 条
  • [21] mTOR inhibitors, bevacizumab
    Escudier, B.
    EJC SUPPLEMENTS, 2009, 7 (02): : 62 - 62
  • [22] Chemistry around imidazopyrazine and ibuprofen: Discovery of novel fatty acid amide hydrolase (FAAH) inhibitors
    De Wael, Frederic
    Muccioli, Giulio G.
    Lambert, Didier M.
    Sergent, Therese
    Schneider, Yves-Jacques
    Rees, Jean-Francois
    Marchand-Brynaert, Jacqueline
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2010, 45 (09) : 3564 - 3574
  • [23] Fused Imidazopyrazine-Based Tubulin Polymerization Inhibitors Inhibit Neuroblastoma Cell Function
    Thammathong, Joshua
    Chisam, Kaylee B.
    Tessmer, Garrett E.
    Womack, Carl B.
    Sidrak, Mario M.
    Weissmiller, April M.
    Banerjee, Souvik
    ACS MEDICINAL CHEMISTRY LETTERS, 2023, 14 (09): : 1284 - 1294
  • [24] mTOR Pathway and mTOR Inhibitors as Agents for Cancer Therapy
    Baldo, Paolo
    Cecco, Sara
    Giacomin, Elisa
    Lazzarini, Renzo
    Rose, Barbara
    Marastoni, Stefano
    CURRENT CANCER DRUG TARGETS, 2008, 8 (08) : 647 - 665
  • [25] Dissecting the role of mTOR: Lessons from mTOR inhibitors
    Dowling, Ryan J. O.
    Topisirovic, Ivan
    Fonseca, Bruno D.
    Sonenberg, Nahum
    BIOCHIMICA ET BIOPHYSICA ACTA-PROTEINS AND PROTEOMICS, 2010, 1804 (03): : 433 - 439
  • [26] Are calcineurin inhibitors safer than mTOR inhibitors?
    Heidi Yeh
    James F. Markmann
    Nature Reviews Nephrology, 2013, 9 : 11 - 13
  • [27] Replacing calcineurin inhibitors with mTOR inhibitors in children
    Sindhi, R
    Seward, J
    Mazariegos, G
    Soltys, K
    Seward, L
    Smith, A
    Kosmach, B
    Venkataramanan, R
    PEDIATRIC TRANSPLANTATION, 2005, 9 (03) : 391 - 397
  • [28] mTOR Signaling Pathway and mTOR Inhibitors in Cancer Therapy
    Gomez-Pinillos, Alejandro
    Ferrari, Anna C.
    HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA, 2012, 26 (03) : 483 - +
  • [29] The mTOR Signaling Pathway and mTOR Inhibitors in Cancer: Next-generation Inhibitors and Approaches
    Ihlamur, Murat
    Akgul, Busra
    Zengin, Yagmur
    Korkut, Senay Vural
    Kelleci, Kubra
    Abamor, Emrah Sefik
    CURRENT MOLECULAR MEDICINE, 2024, 24 (04) : 478 - 494
  • [30] Conversion from calcineurin inhibitors to mTOR inhibitors
    Bodziak, Kenneth A.
    Hrick, Donald E.
    CURRENT OPINION IN ORGAN TRANSPLANTATION, 2007, 12 (04) : 351 - 356
12345